VSee Lab, Inc./iDoc Virtual Telehealth Solutions, Inc. (VSEE)
NASDAQ: VSEE · IEX Real-Time Price · USD
4.519
-1.471 (-24.55%)
At close: Jul 19, 2024, 4:00 PM
4.500
-0.019 (-0.42%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
Company Description
VSee Health, Inc. provides telehealth care solutions.
The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions.
Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
VSee Lab, Inc./iDoc Virtual Telehealth Solutions, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 40 |
| CEO | Ms. Erika Chuang Ph.D. |
Contact Details
Address: 980 N Federal Hwy, #304 Boca Raton, Florida 33432 United States | |
| Phone | (561) 672-7068 |
Stock Details
| Ticker Symbol | VSEE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001864531 |
| ISIN Number | US92919Y1029 |
| Employer ID | 86-2970927 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Scott J. Wolf M.D. | Chief Executive Officer, Corporate Secretary and Chairman |
| Daniel J. Sullivan | Chief Financial Officer, Treasurer and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 17, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jul 15, 2024 | 8-K | Current Report |
| Jul 9, 2024 | D | Notice of Exempt Offering of Securities |
| Jul 9, 2024 | 8-K | Current Report |
| Jul 5, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jul 1, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Jul 1, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Jul 1, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Jun 28, 2024 | 8-K | Current Report |
| Jun 24, 2024 | 25-NSE | Filing |